Skip to content

The research for postoperative neurocognitive impairment in elderly patients by desflurane combined with dexmedetomidine

The research for postoperative neurocognitive impairment in elderly patients by desflurane combined with dexmedetomidine

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900023385
Enrollment
Unknown
Registered
2019-05-25
Start date
2019-05-27
Completion date
Unknown
Last updated
2019-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients under general anesthesia

Interventions

experimental group :Desflurane combined with dexmedetomidine
control group:Desflurane

Sponsors

The First People’s Hospital of Shuangliu District, Chengdu
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. For patients undergoing elective general anesthesia for 1 to 2 hours, endotracheal catheter should be removed after surgery; 2. Aged over 60 years; 3. ASA classification: level I~ II; 4. MMSE score is greater than 24; 5. Subjects will sign the informed consent voluntarily;

Exclusion criteria

Exclusion criteria: 1. Allergic or abnormal reaction to desflurane; 2. Allergic or abnormal reaction to dexmedetomidine; 3. Preoperative patients with cognitive dysfunction and hearing impairment; 4. A history of long-term use of narcotic analgesics, sedatives and antidepressants; 5. Body mass index (BMI) 35kg/m2; 6. Preoperative acute infection; 7. Patients who cannot be followed up; 8. Participated in other clinical trials within three months before the included study; 9. With history of serious cardiovascular diseases (e.g., coronary heart disease or congenital heart disease, grade 3 or above cardiac function); 10. With history of alcohol and drug use; 11. Suffering from mental disorders, unable to communicate normally.

Design outcomes

Primary

MeasureTime frame
MMSE score before and 24 hours after anesthesia;

Secondary

MeasureTime frame
blood routine examination;Blood IL-6 level 24 h after surgery;Blood TNFa level 24 h after surgery;Demographic data;

Countries

China

Contacts

Public ContactLin Hui

The First People’s Hospital of Shuangliu District, Chengdu

51775297@qq.com+86 15388162400

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026